Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Gary Staley has filed a Form 144 to sell common shares of issuer VIAV. The notice covers 22,306 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $583,078.84, based on the figures disclosed.
The filing also lists earlier sales during the past three months. On 02/03/2026, Staley sold 20,742 common shares for gross proceeds of $537,632.64, and on 02/02/2026 he sold 22,784 common shares for $588,405.54. The shares being sold were acquired over several years through restricted stock, performance shares, and an employee stock purchase plan.
A shareholder associated with VIAV has filed a notice of proposed sale of 50,000 shares of common stock, to be executed through Morgan Stanley Smith Barney LLC on or about 02/03/2026 on the NASDAQ. The filing lists an aggregate market value of $1,293,190.00 for these shares and notes that 231,389,345 shares of the same class are outstanding.
The securities to be sold were acquired through restricted stock vesting under a registered plan on dates ranging from 2019 to 2025. The filing also reports that THE JABBAR FAMILY TRUST sold 30,000 common shares on 11/26/2025 for $539,073.00 during the prior three months.
Viavi Solutions shareholder Gary Staley has filed a notice of proposed share sales under Rule 144. The filing covers plans to sell 20,742 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 537,632.64, on or around 02/03/2026 on the NASDAQ.
The issuer had 231,389,345 shares of common stock outstanding at the time referenced. Over the prior three months, Staley sold 22,784 common shares for gross proceeds of 588,405.54. The securities to be sold were originally acquired from the issuer as performance shares and restricted stock between 02/15/2020 and 09/15/2022.
Viavi Solutions Inc. senior vice president Gary W. Staley reported selling 20,742 shares of common stock on February 3, 2026 at $25.92 per share. This insider transaction was filed as a Form 4 and is classified as a direct ownership sale.
After the sale, Staley directly beneficially owns 182,810 shares of Viavi Solutions common stock. He serves as SVP Global Sales NSE, so these holdings and transactions reflect equity tied to a key operating executive.
Viavi Solutions Inc. (VIAV) senior vice president of Global Sales NSE Gary W. Staley reported open-market sales of company common stock. On February 2, 2026, he sold 5,646 shares at a weighted average price of $25.85 and 17,138 shares at a weighted average price of $25.82, both executed in multiple trades within narrow price ranges. After these transactions, he directly beneficially owned 203,552 shares of Viavi common stock.
Viavi Solutions executive Paul McNab reported a sale of 4,638 shares of common stock. The transaction took place on February 2, 2026 at a weighted average price of $25.80 per share, in multiple trades between $25.79 and $25.81.
Following this sale, McNab beneficially owns 21,749 shares of Viavi Solutions common stock in direct ownership. The filing notes his role as EVP, Chief Marketing & Strategy Officer and confirms he will provide detailed trade breakdowns to regulators or shareholders upon request.
Viavi Solutions Inc. executive Kevin Christopher Siebert, SVP, General Counsel & Secretary, sold 13,577 shares of common stock on 02/02/2026 at a weighted average price of $25.72 per share. Following this sale, he beneficially owns 35,648 shares directly.
The sale was executed in multiple trades within a price range of $25.72 to $25.73, with the reported price reflecting the weighted average.
A holder of Viavi Solutions Inc. (VIAV) common stock has filed a Form 144 notice for a planned sale of 22,784 shares, with an aggregate market value of 588,405.54. The shares are expected to be sold on 02/02/2026 on the NASDAQ market through Morgan Stanley Smith Barney LLC Executive Financial Services.
The securities to be sold consist of 17,138 common shares acquired as restricted stock on 08/28/2019 and 5,646 common shares acquired through an employee stock purchase plan on 01/31/2020, both from the issuer. The filing notes that 231,389,345 common shares were outstanding.
Viavi Solutions shareholder Paul A McNab has filed a notice to sell 4,638 common shares under Rule 144. The planned sale, to be executed through Morgan Stanley Smith Barney LLC, has an aggregate market value of $119,647.41 and is expected around 02/02/2026 on the NASDAQ.
The notice shows these shares were acquired through restricted stock and performance share awards in 2024 and 2025. It also lists prior sales over the past three months totaling 14,274 common shares for gross proceeds of $249,672.82. Viavi had 231,389,345 common shares outstanding, providing scale context for these transactions.
Viavi Solutions insider Kevin Siebert has filed a Rule 144 notice to sell 13,577 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NASDAQ, has an aggregate market value of $349,205.87. Shares outstanding were 231,389,345 common shares as of the filing.
In the past three months, Siebert sold 24,225 common shares on 12/08/2025 for gross proceeds of $442,280.67 and 11,148 common shares on 11/03/2025 for gross proceeds of $192,795.74. The shares to be sold were acquired from the issuer via performance share and restricted stock awards between 2019 and 2022.